Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 27;85(6):2617-2627.
doi: 10.1097/MS9.0000000000000466. eCollection 2023 Jun.

Anti-inflammatory potential of 1- O-methyl chrysophanol from Amycolatopsis thermoflava ICTA 103: an exploratory study

Affiliations

Anti-inflammatory potential of 1- O-methyl chrysophanol from Amycolatopsis thermoflava ICTA 103: an exploratory study

Uma Rajeswari Batchu et al. Ann Med Surg (Lond). .

Abstract

The present study was designed to investigate the anti-inflammatory potential of Amycolatopsis thermoflava producing 1-O-methyl chrysophanol (OMC), a member of the hydroxyanthraquinone family. The anti-inflammatory potential was evaluated initially through in silico analysis against tumor necrosis factor- α and cyclooxygenase-2. The same activity was further confirmed based on the in vitro protein denaturation method as well as in vivo by a carrageenan-induced paw edema model in rats. The OMC compound was isolated, purified, and characterized from the fermentation broth of Amycoloptosis thermoflava. In vitro data revealed that the OMC possesses significant protein denaturation properties with an IC50 of 63.50±2.19 µg/ml higher than the standard drug, with an IC50 value of 71.42±0.715 µg/ml. The percentage of inhibition in paw swelling was observed to be 40.03±5.5 in OMC-treated group, which is comparable to the standard group (52.8±4.7). The histopathological evaluation and immunohistochemistry revealed the anti-inflammatory potential of OMC.

Keywords: 1-O-methyl chrysophanol; amycolatopsis thermoflava; anti-inflammatory; carrageenan-induced paw edema model; molecular docking studies; protein denaturation.

PubMed Disclaimer

Conflict of interest statement

The authors declared that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Interaction of TNF-α with OMC (A) 3D structure (B) Ligplot structure.
Figure 2
Figure 2
Interaction of TNF-α with Indomethacin (A) 3D structure (B) Ligplot structure.
Figure 3
Figure 3
Interaction of COX-2 with Indomethacin (A) 3D structure (B) Ligplot structure.
Figure 4
Figure 4
Interaction of COX-2 with OMC (A) 3D structure (B) Ligplot structure.
Figure 5
Figure 5
In vitro effect of OMC on protein denaturation.
Figure 6
Figure 6
In vivo inhibitory effect of OMC on Carrageenan-induced rat paw edema.
Figure 7
Figure 7
Histopathology of rat paw tissue (H&E stain - 10×magnification): (A) Vehicle control (B) 1% Carrageenan-induced (C) Carrageenan + indomethacin (D) Carragenan + OMC. Arrows indicate the infiltration of acute inflammatory cells.
Figure 8
Figure 8
Effect of OMC on histopathology of carrageenan-induced rat paw tissue: (A) Inflammatory cells (B) Edema. *P<0.001 level of statistical significance.
Figure 9
Figure 9
Immunohistochemical evaluation of rat paw tissue (A) CD80 (B)Arginase (C) CD 31 (D) CD68. Arrows indicate the staining area.
Figure 10
Figure 10
Effect of OMC on levels of (A) Arginase-I (B) CD80 (C) CD 31 (D) CD68 in rat paw tissue. *P<0.001 level of statistical significance.

References

    1. Harikrishnan S, Jeemon P, Mini GK, et al. . GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2018;18:32203–32207. - PMC - PubMed
    1. Tskhay A Yezhova A and Alibek K. COVID-19 Pandemic: Is Chronic Inflammation a Major Cause of Death? medRxiv . 2020. 10.1101/2020.05.12.20099572. - DOI
    1. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010;140:771–776. - PubMed
    1. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nature immunology 2005;6:1191–1197. - PubMed
    1. Kumar V, Cotran RS, Robbins SL. Robbins Basic Pathology. Saunders; 2003.